Literature DB >> 2864575

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

D Serwadda, R D Mugerwa, N K Sewankambo, A Lwegaba, J W Carswell, G B Kirya, A C Bayley, R G Downing, R S Tedder, S A Clayden, R A Weiss, A G Dalgleish.   

Abstract

A new disease has recently been recognised in rural Uganda. Because the major symptoms are weight loss and diarrhoea, it is known locally as slim disease. It is strongly associated with HTLV-III infection (63 out of 71 patients) and affects females nearly as frequently as males. The clinical features are similar to those of enteropathic acquired immunodeficiency syndrome as seen in neighbouring Zaire. However, the syndrome is rarely associated with Kaposi's sarcoma (KS), although KS is endemic in this area of Uganda. Slim disease occurs predominantly in the heterosexually promiscuous population and there is no clear evidence to implicate other possible means of transmission, such as by insect vectors or re-used injection needles. The site and timing of the first reported cases suggest that the disease arose in Tanzania.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Antibodies; Behavior; Cancer; Communicable Diseases; Control Groups; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Measurement; Neoplasms; Physical Examinations And Diagnoses; Prevalence; Research Methodology; Sex Behavior; Signs And Symptoms; Tanzania; Uganda; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 2864575     DOI: 10.1016/S0140-6736(85)90122-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  121 in total

1.  Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Authors:  R Thiébaut ; D Malvy; C Marimoutou; F Davis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.

Authors:  M A McNurlan; P J Garlick; R T Steigbigel; K A DeCristofaro; R A Frost; C H Lang; R W Johnson; A M Santasier; C J Cabahug; J Fuhrer; M C Gelato
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Mobility among youth in Rakai, Uganda: Trends, characteristics, and associations with behavioural risk factors for HIV.

Authors:  Ashley C Schuyler; Zoe R Edelstein; Sanyukta Mathur; Joseph Sekasanvu; Fred Nalugoda; Ronald Gray; Maria J Wawer; David M Serwadda; John S Santelli
Journal:  Glob Public Health       Date:  2015-08-27

4.  Sexually transmitted viral infections in various population groups in Mogadishu, Somalia.

Authors:  H Jama; L Grillner; G Biberfeld; S Osman; A Isse; M Abdirahman; S Bygdeman
Journal:  Genitourin Med       Date:  1987-10

Review 5.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

6.  HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Authors:  Sam M Mbulaiteye; Kishor Bhatia; Clement Adebamowo; Annie J Sasco
Journal:  Infect Agent Cancer       Date:  2011-10-17       Impact factor: 2.965

Review 7.  Human immunodeficiency virus-induced enteropathy.

Authors:  R Ullrich; E O Riecken; M Zeitz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

8.  For debate. AIDS surveillance in Africa: a reappraisal of case definitions.

Authors:  K M De Cock; R M Selik; B Soro; H Gayle; R L Colebunders
Journal:  BMJ       Date:  1991-11-09

9.  HIV/AIDS Stigmatization, the Reason for Poor Access to HIV Counseling and Testing (HCT) Among the Youths in Gulu (Uganda).

Authors:  D L Kitara; J Aloyo
Journal:  Afr J Infect Dis       Date:  2012

10.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.